Venous Thromboembolism and Joint Replacement is organized by Medical Interactive Community
Release Date: Dec14, 2016
Expiration Date: Dec 14, 2019
Orthopedic surgeons and in addition, hospitalists, internists, family physicians, cardiologists, anesthesiologists, and other physicians who may collaborate in decisions and treatment associated with anticoagulation of patients undergoing total joint replacement surgery. Other interested healthcare practitioners are also welcome to participate.
About 1 million new total joint replacements (TJRs) are performed each year. A relatively common and often serious complication of major orthopedic surgery is venous thromboembolism (VTE). Patients rely on their physicians to help them understand their risk of VTE and to choose appropriate anticoagulant therapy. Therefore, physicians and surgeons need to be aware of the various prophylactic treatments available for preventing VTE following TJR.
Upon completion, participants should be able to:
• Describe the mechanism of venous thromboembolism (VTE)
• Describe the mechanisms and properties of various anticoagulants used in VTE prophylaxis related to total joint replacement
• Summarize the American College of Chest Physicians guidelines for preventing VTE in orthopedic surgery patients
• List the risks of anticoagulant treatment for VTE prophylaxis
• Describe the reversal therapies for anticoagulants
Additional details will be posted as soon as they are available.
Cardiology, Orthopedic Surgery